Overview: Quinolinic Acid TestIntroduction: The Quinolinic Acid Test tests for quinolinic acid to assess neurological or inflammatory disorders, helping diagnose causes of cognitive issues or fatigue. Affecting 1 in 10,000 people with neurological conditions, quinolinic acid elevation poses diagnostic challenges due to complex pathways. Following 2023 National Institute of Neurological Disorders and Stroke (NINDS) guidelines, it uses LC-MS/MS for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, treatment planning, and improving outcomes in neurology.
Other Names: Quinolinic Acid Level Test, Neuroinflammation Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Quinolinic acid testing began in the 1980s with research by Heyes, who linked it to neurotoxicity. LC-MS/MS advancements in the 2000s by Waters improved detection, surpassing earlier HPLC methods.
Purpose: Measures quinolinic acid levels to diagnose neurological or inflammatory disorders, guides anti-inflammatory therapy, and evaluates patients with cognitive issues, aiming to manage symptoms.
Test Parameters: Quinolinic acid levels
Pretest Condition: No special preparation required. Collect urine, plasma, or CSF. Report history of neurological issues.
Specimen: Urine (sterile container, 5-20 mL), Plasma (NaHep, 2-4 mL), CSF (sterile container, 1-2 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document cognitive issues or fatigue. Include current medications or infection history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., dementia), and sample collection risks.
Procedural Considerations: Uses LC-MS/MS to measure levels, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Elevated levels suggest neurological or inflammatory disorder, guiding therapy. Early treatment might prevent progression, while untreated cases lead to worsening. Normal levels may require other tests.
Specialist Consultation: Consult a neurologist for interpretation.
Additional Supporting Tests: MRI, kynurenic acid levels, or inflammatory markers to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False negatives possible with mild cases.
References: NINDS Guidelines, 2023; Journal of Neurochemistry, Heyes MP, 2022.
